ST PHARM CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100,000 KRW | -1.77% |
|
+9.65% | +47.49% |
| 2023 | ST Pharm Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| 2021 | ST Pharm Co.,Ltd. Announces Expansion of Oligonucleotide Facility | CI |
Evolution of the average Target Price on ST Pharm Co.,Ltd.
Price target over the last 5 years
History of analyst recommendation changes
a2a1ffcb244b9c3cc8649a3fb8.OZFPYgB0vWk95_jvZFG9iLiIghO8_1fxUaXCD-h04eU.FNU_DUJNyV5EnsiFVADc18z_ymfQkmTIIs-ERZEjrbN_2iYxdR7PJEe3zA~b30410059104d81766d1829e25078cef
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
100,000
KRW
Average target price
105,000
KRW
Spread / Average Target
+5.00%
High Price Target
140,000
KRW
Spread / Highest target
+40.00%
Low Price Target
100,000
KRW
Spread / Lowest Target
0.00%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- A237690 Stock
- Consensus ST Pharm Co.,Ltd.
